Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Developing Novel Diagnostic Tests To Improve Surveillance for Antimicrobial Resistant Pathogens, Funding Opportunity Announcement (FOA) CI10-002; Initial Review, 21339 [2010-9519]

Download as PDF Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Notices meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–9523 Filed 4–22–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Developing Novel Diagnostic Tests To Improve Surveillance for Antimicrobial Resistant Pathogens, Funding Opportunity Announcement (FOA) CI10–002; Initial Review WReier-Aviles on DSKGBLS3C1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., May 18, 2010 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Clifton Road, Atlanta, GA 30337, Telephone: (770) 979–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Developing Novel Diagnostic Tests to Improve Surveillance for Antimicrobial Resistant Pathogens, FOA CI10–002.’’ Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 19, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Dated: April 19, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Administration for Children and Families National Institute of Environmental Health Sciences; Notice of Closed Meeting Notice of Meeting; National Commission on Children and Disasters Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Clinical and Pediatric Loan Repayment Research Review. Date: May 13, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: NIEHS/National Institutes of Health, Keystone, 530 Davis Drive, Research Triangle Park, NC 27709, (Virtual Meeting). Contact Person: Leroy Worth, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30/Room 3171, Research Triangle Park, NC 27709, (919) 541–0670, worth@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: April 16, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–9454 Filed 4–22–10; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2010–9519 Filed 4–22–10; 8:45 am] BILLING CODE 4163–18–P VerDate Nov<24>2008 15:23 Apr 22, 2010 Jkt 220001 21339 PO 00000 Frm 00120 Fmt 4703 Sfmt 4703 AGENCY: Administration for Children and Families, Department of Health and Human Services. ACTION: Notice of meeting. DATES: The meeting will be held on Tuesday, May 11, 2010, from 10:30 a.m. to 3:30 p.m. ADDRESSES: The meeting will be held at the Administration for Children and Families, 901 D Street, SW., Washington, DC 20024. To attend either in person or via teleconference, please register by 5 p.m. Eastern Time, May 5, 2010. To register, please e-mail jacqueline.haye@acf.hhs.gov with ‘‘Meeting Registration’’ in the subject line, or call (202) 205–9560. Registration must include your name, affiliation, and phone number. If you require a sign language interpreter or other special assistance, please call Jacqueline Haye at (202) 205–9560 or e-mail jacqueline.haye@acf.hhs.gov as soon as possible and no later than 5 p.m. Eastern Time, April 27, 2010. Agenda: The Commission will discuss: (1) Ad-hoc progress report on recommendations; (2) reports of Subcommittees; and (3) report on field visit to Florida. Written comments may be submitted electronically to roberta.lavin@acf.hhs.gov with ‘‘Public Comment’’ in the subject line. The Commission recommends that you include your name, mailing address and an e-mail address or other contact information in the body of your comment. This ensures that you can be identified as the submitter of the comment, and it allows the Commission to contact you if further information on the substance of the comment is needed or if your comment cannot be read due to technical difficulties. The Commission’s policy is that the Commission will not edit your comment, and any identifying or contact information provided in the body of a comment will be included as part of the comment placed in the official record. The Commission will provide an opportunity for public comments during the public meeting on May 11, 2010. Those wishing to speak will be limited to three minutes each; speakers are encouraged to submit their remarks in writing in advance to ensure their comment is received in case there is E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 75, Number 78 (Friday, April 23, 2010)]
[Notices]
[Page 21339]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Developing Novel Diagnostic Tests To Improve 
Surveillance for Antimicrobial Resistant Pathogens, Funding Opportunity 
Announcement (FOA) CI10-002; Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 8 a.m.-5 p.m., May 18, 2010 (Closed).
    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Clifton 
Road, Atlanta, GA 30337, Telephone: (770) 979-1100.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Developing Novel Diagnostic Tests to Improve 
Surveillance for Antimicrobial Resistant Pathogens, FOA CI10-002.''
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-2293.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 19, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-9519 Filed 4-22-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.